KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Restructuring Costs (2016 - 2024)

Bausch Health Companies' Restructuring Costs history spans 16 years, with the latest figure at -$2.0 million for Q4 2024.

  • For Q4 2024, Restructuring Costs rose 33.33% year-over-year to -$2.0 million; the TTM value through Sep 2024 reached -$1.0 million, down 116.67%, while the annual FY2022 figure was $33.0 million, 3.12% up from the prior year.
  • Restructuring Costs for Q4 2024 was -$2.0 million at Bausch Health Companies, down from $2.0 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $13.0 million in Q2 2022 and bottomed at -$3.0 million in Q4 2023.
  • The 5-year median for Restructuring Costs is $5.0 million (2021), against an average of $5.4 million.
  • The largest annual shift saw Restructuring Costs skyrocketed 233.33% in 2020 before it plummeted 200.0% in 2023.
  • A 5-year view of Restructuring Costs shows it stood at $10.0 million in 2020, then increased by 20.0% to $12.0 million in 2021, then crashed by 75.0% to $3.0 million in 2022, then tumbled by 200.0% to -$3.0 million in 2023, then soared by 33.33% to -$2.0 million in 2024.
  • Per Business Quant, the three most recent readings for BHC's Restructuring Costs are -$2.0 million (Q4 2024), $2.0 million (Q3 2024), and -$3.0 million (Q4 2023).